Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00931710 · ClinicalTrials.gov registry record · Phase 4
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
- 488
- Enrollment target
NCT00931710: Completed Phase 4 study, sponsored by Novartis.
NCT00931710 is a Phase 4 study that has completed, run by Novartis. The registered enrollment target is 488 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00931710, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 488 participants
- Enrollment target
Study Summary
This study will compare the antihypertensive efficacy and safety of a valsartan/amlodipine-based treatment with a losartan-based treatment in patients with Stage 2 systolic hypertension (high blood pressure, mean systolic blood pressure greater than 160 and less than 200 mmHg).
Primary Outcome
To compare the change from baseline in mean sitting systolic blood pressure (MSSBP) after 6 weeks of valsartan/amlodipine-based regimen with a losartan-based regimen in patients with Stage 2 systolic hypertension.
Interventions
- DRUG valsartan, amlodipine, HCTZ
- DRUG Losartan, HCTZ followed by valsartan, amlodipine, HCTZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT00931710 record still lists
NCT00931710 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which valsartan, amlodipine, HCTZ is the first listed.
NCT00931710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00931710 about?
NCT00931710 is a clinical study titled "Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension". This study will compare the antihypertensive efficacy and safety of a valsartan/amlodipine-based treatment with a losartan-based treatment in patients with Stage 2 systolic hypertension (high blood pressure, mean systolic blood pressure greater than 160 and less than 200 mmHg).
What is the current status of trial NCT00931710?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 488 participants. The study started on 2009-07. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00931710?
The interventions under investigation include: valsartan, amlodipine, HCTZ (DRUG), Losartan, HCTZ followed by valsartan, amlodipine, HCTZ (DRUG).
Who is sponsoring clinical trial NCT00931710?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00931710's enrollment target sits among peer trials
488 180th of 2000 higher than 1,821 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05154669 · 488 participants · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06794983 · 488 participants · NA
Calls and Coordination for Transitions of Care at Re-entry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia